Cargando…

Beware of Rhabdomyolysis After a Renal Graft

In recent years, there has been a significant advancement in the field of immunosuppressive therapy in renal transplantation. However, these treatments have side effects, including rhabdomyolysis. In this article, we report the case of a transplant patient with rhabdomyolysis secondary to tacrolimus...

Descripción completa

Detalles Bibliográficos
Autores principales: El Bardai, Ghita, Chouhani, Basmat Amal, Haddane, Widad, Kabbali, Nadia, Sqalli Houssaini, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676010/
https://www.ncbi.nlm.nih.gov/pubmed/36415354
http://dx.doi.org/10.7759/cureus.30546
_version_ 1784833497909690368
author El Bardai, Ghita
Chouhani, Basmat Amal
Haddane, Widad
Kabbali, Nadia
Sqalli Houssaini, Tarik
author_facet El Bardai, Ghita
Chouhani, Basmat Amal
Haddane, Widad
Kabbali, Nadia
Sqalli Houssaini, Tarik
author_sort El Bardai, Ghita
collection PubMed
description In recent years, there has been a significant advancement in the field of immunosuppressive therapy in renal transplantation. However, these treatments have side effects, including rhabdomyolysis. In this article, we report the case of a transplant patient with rhabdomyolysis secondary to tacrolimus and shed light on different aggravating factors. Treatment withdrawal, hydration, and forced diuresis are allowed in the majority of cases.
format Online
Article
Text
id pubmed-9676010
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96760102022-11-21 Beware of Rhabdomyolysis After a Renal Graft El Bardai, Ghita Chouhani, Basmat Amal Haddane, Widad Kabbali, Nadia Sqalli Houssaini, Tarik Cureus Nephrology In recent years, there has been a significant advancement in the field of immunosuppressive therapy in renal transplantation. However, these treatments have side effects, including rhabdomyolysis. In this article, we report the case of a transplant patient with rhabdomyolysis secondary to tacrolimus and shed light on different aggravating factors. Treatment withdrawal, hydration, and forced diuresis are allowed in the majority of cases. Cureus 2022-10-21 /pmc/articles/PMC9676010/ /pubmed/36415354 http://dx.doi.org/10.7759/cureus.30546 Text en Copyright © 2022, El Bardai et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Nephrology
El Bardai, Ghita
Chouhani, Basmat Amal
Haddane, Widad
Kabbali, Nadia
Sqalli Houssaini, Tarik
Beware of Rhabdomyolysis After a Renal Graft
title Beware of Rhabdomyolysis After a Renal Graft
title_full Beware of Rhabdomyolysis After a Renal Graft
title_fullStr Beware of Rhabdomyolysis After a Renal Graft
title_full_unstemmed Beware of Rhabdomyolysis After a Renal Graft
title_short Beware of Rhabdomyolysis After a Renal Graft
title_sort beware of rhabdomyolysis after a renal graft
topic Nephrology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676010/
https://www.ncbi.nlm.nih.gov/pubmed/36415354
http://dx.doi.org/10.7759/cureus.30546
work_keys_str_mv AT elbardaighita bewareofrhabdomyolysisafterarenalgraft
AT chouhanibasmatamal bewareofrhabdomyolysisafterarenalgraft
AT haddanewidad bewareofrhabdomyolysisafterarenalgraft
AT kabbalinadia bewareofrhabdomyolysisafterarenalgraft
AT sqallihoussainitarik bewareofrhabdomyolysisafterarenalgraft